Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor A. López-Colombo, M.S. Pacio-Quiterio, L.Y. Jesús-Mejenes, J.E.G. Rodríguez-Aguilar, M. López-Guevara, A.J. Montiel-Jarquín, J.C. López-Alvarenga, E.R. Morales-Hernández, V.R. Ortiz-Juárez, L. Ávila-Jiménez

Symptomatic recurrence upon proton pump inhibitor discontinuation correlated with results of Bravo® wireless esophageal pH monitoring in patients with gastroesophageal reflux disease Enrique Coss-Adame

Degree of concordance on the management of patients with gastroesophageal reflux disease. A study among specialists that are members of the Sociedad Latinoamericana de Neurogastroenterología (SLNG) L. Soifer, J. Tawil, J.M. Remes-Troche, M.A. Valdovinos, M. Schmulson